Dr. Nasser Bayati, MD

Dr. Bayati practices at Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare.

Dr. Bayati's NPI, 1902851744, was assigned on May 23, 2006. Dr. Bayati graduated from Tabriz University of Medical Sciences in 1990. Dr. Bayati holds California license A83515.

Dr. Bayati's primary practice is Sharp Chula Vista Medical Center, at 751 Medical Center Court, Chula Vista, CA 91911 in San Diego County. The practice phone is (619) 502-5800.

Dr. Bayati's primary practice is Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare. Dr. Bayati is also affiliated with Palomar Medical Center Downtown Escondido. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Bayati to 3 more medical groups, 1 physician office, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bayati practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Bayati's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Bayati is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bayati's licenses on file in 2 states: California and Michigan.

Dmand AI lists acute respiratory failure, bile duct problems, cellulitis, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, gastrointestinal inflammation and gastrointestinal obstruction among the conditions Dr. Bayati treats.

CMS data shows 1,015 Medicare services from Dr. Bayati across 4 procedure codes in 2024, for 237 Medicare patients. Medicare paid $88,254 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Bayati in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bayati's median patient age at 75, with 52% women.

In 2024, Dr. Bayati wrote 787 Medicare Part D claims for 252 patients. 85% of them were for generic drugs. CMS names the drug for 413 of them, across 16 drugs with 11 or more claims each, at $26,066 in total drug cost. In 2023, CMS named 366 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bayati for performance year 2024, reported as part of a group. Dr. Bayati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Bayati. The most frequent topics are Liver, Antiviral Agents and Hepatitis C, Chronic. Dr. Bayati has published most often in Am J Gastroenterol.

CMS Open Payments shows 19 general payments to Dr. Bayati from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $433.

Dr. Bayati graduated from Tabriz University of Medical Sciences in 1990. Dr. Bayati is a member of SHM.

Dr. Bayati is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.